Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

M&A Analysis: M&A Rises In 2017 As Market Set To Bounce Back In 2018

Executive Summary

2017 proved to be a busy year for medtech M&A activity, with the number of deals rising from 174 in 2016, to 206 in 2017. The year also brought a number of notable acquisitions, including Becton Dickinson's blockbuster $24bn purchase of CR Bard and Dutch health-care giant Philips undertaking an ambitious acquisition spree. Medtech Insight takes a look at the highlights of 2017 and what's in store for 2018.

Advertisement

Related Content

Market Intel: Bioelectronics, Imaging Fortify Medtech's Defense Against Rheumatoid Arthritis
US Approvals Analysis: Hits Just Keep On Coming. Can It Last?
Philips Grows Image-Guided Intervention Focus With Spectranetics Buy
Stryker Doubles Down On Novadaq To Boost Medsurg
BD, CR Bard Merger To Create Vascular Access Device Giant
Hologic Stitches Medical Aesthetics Into Women's Health
M&A Analysis: Underwhelming 2016, But Hope For 2017 US Market Boom

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT121985

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel